Top compounds associated with response to CRK


Feature Type Standardized
Nominal ANOVA
mRNA LRRK2-IN-1 CTRPv2 pan-cancer AAC -0.12 0.006
mRNA COL-3 CTRPv2 pan-cancer AAC -0.12 0.006
mRNA PX-12 CTRPv2 pan-cancer AAC -0.092 0.006
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.007
mRNA lenalidomide GDSC1000 pan-cancer AAC 0.12 0.007
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.008
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.008
mRNA KPT185 CTRPv2 pan-cancer AAC -0.12 0.008
mRNA prima-1 CTRPv2 pan-cancer AAC -0.097 0.008
mRNA CD-437 CTRPv2 pan-cancer AAC -0.099 0.009
Download CSV